Details of the Drug

General Information of Drug (ID: DMWMPD8)

Drug Name

SSR-97225

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00547261) Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer. U.S. National Institutes of Health.